A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine
Study sponsor: Vaxart
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-06-10Actual
Enrollment · participants66Actual
Source updated2025-04-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.